PAR
Click for more information
4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-39

  1. Denial
    9,802 Posts.
    lightbulb Created with Sketch. 1243
    clock Created with Sketch.
    01/11/21
    09:33
    Post #: 57220965
    That's complete BS as the FDA green light often includes further/final clarification which impacts the P3 itself. This clarification will then be reviewed to understand the implications and communicated to the market (i.e. shareholders)


    PAR Price at posting: $2.06 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
NEWS Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
ARU Arafura updates gas supply agreement with Mereenie JV for 16.4PJ supply to Nolans REE play
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢ 		Change
0.010(4.08%) 		Mkt cap ! $89.19M
Open High Low Value Volume
24.5¢ 26.0¢ 24.5¢ $64.97K 253.3K

Buyers (Bids)

No. Vol. Price($)
1 794 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 217 1
View Market Depth
Last trade - 15.59pm 01/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.